Skip to content

The application value of myocardial markers combined with left ventricular global longitudinal strain by speckle tracking echocardiography in patients with septic cardiomyopathy in the ICU.

The application value of myocardial markers combined with left ventricular global longitudinal strain by echocardiography in patients with septic cardiomyopathy in the ICU.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093623
Enrollment
Unknown
Registered
2024-12-09
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis - induced cardiomyopathy

Interventions

Sepsis without shock group and sepsis with shock group.:There are no special intervention measures, and corresponding treatments are provided according to the guidelines.
Classification 1 (Subgroup analysis, according to ejection fraction):Ejection fraction = 50 (EF = 50%) and ejection fraction preserved group (40% = EF < 50%), ejection fraction reduced group (EF < 40%
:There are no special intervention measures, and corresponding treatments are provided according to the guidelines.
Classification 2 (Subgroup analysis, according to sepsis phenotypes):a, ß, ?, d subgroups.:There are no special intervention measures, and corresponding treatments are provided according to the guidel

Sponsors

The Second Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Reach the age of 18 years old; ? Sepsis: A definite infectious focus is identified; Organ dysfunction: The Sequential Organ Failure Assessment (SOFA) score is = 2 points, with or without septic shock: Vasoactive drugs are still required to maintain the mean arterial pressure (MAP) = 65 mmHg after sufficient fluid resuscitation; Serum lactate > 2 mmol/L.

Exclusion criteria

Exclusion criteria: ? Acute myocardial dysfunction: such as acute coronary syndrome, unstable arrhythmia (including bundle branch block) and the status after cardiopulmonary resuscitation, etc.; ? Potential heart diseases: such as congenital heart disease, valvular heart disease, etc., a definite history of myocardial infarction, long-term uncontrolled / poorly controlled hypertension, chronic heart failure caused by various reasons; ? Chronic diseases: long-term chronic hypoxic state, chronic anemia, dialysis; ? Acute events: acute bleeding events, the acute onset period of connective tissue diseases; ? After radiotherapy and chemotherapy for tumors, advanced stage of tumors and the terminal state of other chronic diseases; ? Pregnancy state and perinatal period.

Design outcomes

Primary

MeasureTime frame
mean arterial pressure;lactate;Types and Maximum Doses of Vasoactive Drugs;Troponin I;NT - proBNP;Left ventricular global longitudinal strain;left ventricular ejection fraction;The APACHE II score;SOFA Scoring;In - hospital mortality rate;28-day mortality rate;Mortality rate within 3 months;Mortality rate within 6 months;

Secondary

MeasureTime frame
etiology;Vital signs (respiration, heart rate, body temperature).;blood routine test(White blood cell count, neutrophil percentage);biochemical tests(aspartate aminotransferase and alanine aminotransferase, total bilirubin, creatinine, urea nitrogen);coagulation function(Prothrombin activity);Infection Markers (Procalcitonin and Interleukin - 6,C - reactive protein);Length of ICU stay;Duration of ventilator use;Whether continuous renal replacement therapy (CRRT) was carried out.;

Countries

china

Contacts

Public Contactcao wen

The Second Hospital of Lanzhou University

smilecao2009@126.com+86 136 0939 7177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026